We're now armed with the power of gene replacement therapies like the superstars voretigene neparvovec and onasemnogene abeparvovec. They carry the potential to fix the genetic glitches causing inherited retinal diseases. CRISPR/Cas9 gene editing is also stepping up as a possible game-changer in the fight against retinal dystrophies.